Who owns Momenta Pharmaceuticals?

Key details on Momenta Pharmaceuticals (Ticker: MNTA)

Who owns Momenta Pharmaceuticals?

Is MNTA a good stock to own? Find out who bought Momenta Pharmaceuticals, who sold Momenta Pharmaceuticals (MNTA) stock, and who holds a large position in Momenta Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Scopia Management 3.80M $44.80M Dec. 31, 2012
Visium Asset Management 3.62M $64.00M Dec. 31, 2013
T. Rowe Price Associates 3.28M $38.20M March 31, 2014
Vanguard 3.21M $37.36M March 31, 2014
BlackRock Fund Advisors 3.19M $37.15M March 31, 2014
FMR 3.09M $36.02M March 31, 2014
S.A.C. Capital Advisors 3.03M $35.29M March 31, 2014
Wellington Management Company 2.81M $40.93M Sept. 30, 2012
PRIMECAP Management Company 2.16M $25.16M March 31, 2014
STATE STREET CORPORATION 2.05M $23.86M March 31, 2014
Discovery Capital Management 1.93M $34.08M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 1.47M $17.15M March 31, 2014
Acadian Asset Management 1.33M $19.40M Sept. 30, 2012
Palo Alto Investors 1.31M $15.32M March 31, 2014
ALLIANCEBERNSTEIN 1.19M $21.04M Dec. 31, 2013
Deerfield Management Company 1.14M $20.10M Dec. 31, 2013
Sectoral Asset Management 1.11M $12.94M March 31, 2014
Frontier Capital Management 1.10M $13.00M Dec. 31, 2012
DIMENSIONAL FUND ADVISORS 1.05M $12.24M March 31, 2014
GOLDMAN SACHS 1.01M $14.54M Sept. 30, 2013
CITADEL ADVISORS 959053 $14.44M June 30, 2013
Hutchin Hill Capital 950000 $16.53M Dec. 31, 2011
Millennium Management 884848 $10.31M March 31, 2014
SUSQUEHANNA INTERNATIONAL 809951 $9.44M March 31, 2014
Camber Capital Management 800000 $12.05M June 30, 2013
Renaissance Technologies 788751 $9.30M Dec. 31, 2012
Apex Capital Management 781651 $9.44M June 30, 2014
Schroder Investment Management 745100 $10.04M June 30, 2012

Who sold Momenta Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
AQR Capital Management Dec. 31, 2012 727584 $8.57M
OppenheimerFunds June 30, 2011 5.50M $107.07M
Citi March 31, 2011 1.66M $26.30M
OrbiMed Advisors Dec. 31, 2010 2.16M $32.35M
Barclays Dec. 31, 2010 1.70M $25.42M